Robert Molander

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
3
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity May 4, 2021 – Feb 20, 2026

Robert Molander reported 10 transactions between May 4, 2021 and Feb 20, 2026. The buy and sell totals below count only codes SACQ, SDIS.

Open-market buys (SACQ)
205.8K SEK
$139.4K
7 purchases on file priced rows only
Open-market sales (SDIS)
1.19M SEK
$112
2 sales on file priced rows only
All reported transactions
10
every code, including awards and exercises
Pattern
Bought and sold in similar amounts
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

5 insiders bought Infant Bacterial Therapeutics AB shares on May 4, 2021

Cluster buying

5 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Infant Bacterial Therapeutics AB shares on May 4, 2021
Date Insider Transaction Shares Price Value Filing
May 4, 2021 Kristina Sjöblom Nygren SACQ Acquisition 100 91.90 SEK 9,190 SEK FI filing ↗
May 4, 2021 Anders Kronström SACQ Acquisition 1,650 95.26 SEK 157,179 SEK FI filing ↗
May 4, 2021 Staffan Strömberg SACQ Acquisition 1,500 96.70 SEK 145,050 SEK FI filing ↗
May 4, 2021 Peter Rothschild SACQ Acquisition 100,000 93.30 SEK 9,330,000 SEK FI filing ↗
May 4, 2021 Robert Molander SACQ Acquisition 4,000 $11.25 $45,000 FI filing ↗

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 10 most recent rows are grouped into 10 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. SciBase Holding AB (publ) SSUB Subscriptionnot a buy/sell decision 5,952,380 shares 1.19M SEK at 0.20 SEK FI filing ↗
  2. SciBase Holding AB (publ) SDIS Disposal 11,904,760 shares 1.19M SEK at 0.10 SEK FI filing ↗
  3. XSpray Pharma AB (publ) SDIS Disposal 10,000 shares $112 at $0.01 FI filing ↗
  4. XSpray Pharma AB (publ) SACQ Acquisition 5,000 shares $19.9K at $3.98 FI filing ↗
  5. Infant Bacterial Therapeutics AB SACQ Acquisition 20,000 shares 65.8K SEK at 3.29 SEK FI filing ↗
  6. XSpray Pharma AB (publ) SACQ Acquisition 3,000 shares $19.2K at $6.41 FI filing ↗
  7. XSpray Pharma AB (publ) SACQ Acquisition 2,000 shares $12.9K at $6.47 FI filing ↗
  8. Infant Bacterial Therapeutics AB SACQ Acquisition 20,000 shares 140.0K SEK at 7.00 SEK FI filing ↗
  9. Infant Bacterial Therapeutics AB SACQ Acquisition 5,500 shares $42.4K at $7.70 FI filing ↗
  10. Infant Bacterial Therapeutics AB SACQ Acquisition 4,000 shares $45.0K at $11.25 FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Infant Bacterial Therapeutics AB SE0008015259 INFANT BACTERIAL THERAPEUTICS ser. B 9,500 — — FI marknadssok.fi.se ↗
XSpray Pharma AB (publ) SE0009973563 Xspray Pharma AB 10,000 — — FI marknadssok.fi.se ↗
SciBase Holding AB (publ) SE0007045414 Scibase Holding AB 5,952,380 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Robert Molander reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.